NEW YORK, Aug. 26, 2016 -- The securities arbitration law firm of Klayman & Toskes, P.A. ("K&T"), www.nasd-law.com, has filed a $500,000 FINRA arbitration claim [FINRA Case No. 16-01835] on behalf of a United Parcel Service (“UPS”) (NYSE:UPS) employee for losses sustained as a result of Merrill Lynch’s unsuitable recommendation to invest in Rampart Options Management Services Program (“ROMS”). Merrill Lynch offers the ROMS program on a discretionary basis exclusively to high-net-worth clients holding stock positions exceeding $1 million through Rampart Investment Management Company (RIMCO).
According to K&T, the investigation focuses on Merrill Lynch’s sales practices for customers who acquired UPS stock through UPS’ Employee Stock Purchase Plan or Managers Incentive Program and were advised by Merrill Lynch to protect their concentrated UPS stock position through Merrill Lynch’s ROMS program.
Securities attorney Steven D. Toskes from K&T explains, “Merrill Lynch is required to supervise its financial advisors and the recommendations made to customers with concentrated stock positions, including brokerage accounts managed on a discretionary basis which are held to a fiduciary standard of care.” Mr. Toskes also noted that, “The ROMS covered call strategy is not a suitable investment strategy for an entire concentrated stock position. Our client accumulated low cost basis stock during the 30 years they worked for UPS and did not want to have their stock 'called away' and trigger a large capital gains tax.”
K&T continues to represent UPS employees who invested in Rampart Options Management Services against Merrill Lynch for FINRA sales practice violations, including unsuitable recommendations, misrepresentations and omissions of material facts and failure to supervise. Investors who have information about the sales practices of brokerage firms and their financial advisors are encouraged to contact Lawrence L. Klayman, Esq. or Raymond Gentile, Esq. of Klayman & Toskes at (888) 997-9956, or visit our website at www.nasd-law.com.
About Klayman & Toskes, P.A.
K&T is a leading national securities law firm which practices exclusively in the field of securities arbitration and litigation, on behalf of retail and institutional investors throughout the world in large and complex securities matters. The firm represents high net-worth, ultra-high-net-worth, and institutional investors, such as non-profit organizations, unions, public and multi-employer pension funds. K&T has office locations in California, Florida, New York and Puerto Rico.
Contact: Klayman & Toskes, P.A. Lawrence L. Klayman, Esq. Raymond Gentile, Esq. (888)-997-9956 [email protected] www.nasd-law.com


Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



